mRNA flu shots have officially arrived.
On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots. The flu vaccine, called mFlusiva and produced by Moderna, will be available for people ages 50 and older at select drug stores ahead of the upcoming flu season, the Massachusetts-based company said.
Influenza kills thousands of people in the United States each year and hospitalizes tens of thousands more. The FDA’s approval is based on a study of 40,000 individuals who got either a dose of mFlusiva or a conventional flu shot. The mRNA flu shot group…
Read the full article at SCIENCENEWS.ORG
